Pfizer's quarterly profit declined to $2.59 billion, or $0.39 per share, versus a year-ago profit of $3.21 billion, or $0.43 per share, in the year-earlier period. Its adjusted earnings climbed 16 percent to $0.58 per share.
Its revenue fell 2 percent to $12.64 billion from $12.95 billion. However, analysts were projecting earnings of $0.56 per share on revenue of $12.7 billion. Pfizer lowered its 2013 earnings view to $3.05 to $3.15 per share, versus its earlier forecast of $3.07 to $3.22 per share.
Equities Trading UPCommodities
In commodity news, oil traded down 0.70 percent to $97.99, while gold traded down 0.35 percent to $1,347.40.
Silver traded down 0.04 percent Tuesday to $22.53, while copper rose 0.54 percent to $3.29.
The U.S. producer price index declined 0.1 percent in September, while core wholesale prices climbed 0.1 percent. However, economists were expecting a 0.3 percent gain in the overall PPI and a 0.1 percent increase in the core PPI.
The ICSC-Goldman Sachs store sales index dropped 0.4 percent in the week ended Saturday versus the earlier week.
The Johnson Redbook Sales Index declined 1.3 percent in the first three weeks of October versus September.
U.S. business inventories rose 0.30 percent in August, versus a 0.40 percent growth in July. However, economists were expecting a 0.30 percent gain. The Treasury is set to auction 4-week bills and 5-year notes.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.